Drug profile · INN
pilocarpine hydrochloride
PILOCARPINE HYDROCHLORIDE
pilocarpine hydrochloride (PILOCARPINE HYDROCHLORIDE) is a muscarinic acetylcholine receptor m3 agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — pilocarpine hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
pilocarpine hydrochloride (PILOCARPINE HYDROCHLORIDE) is a muscarinic acetylcholine receptor m3 agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M3 agonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pilocarpine hydrochloride?
pilocarpine hydrochloride (PILOCARPINE HYDROCHLORIDE) is a muscarinic acetylcholine receptor m3 agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for pilocarpine hydrochloride?
PILOCARPINE HYDROCHLORIDE is a marketed brand name for pilocarpine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pilocarpine hydrochloride?
pilocarpine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.